India: Covaxin and Covishield vaccines invoke 50% fewer antibodies against B.1.617 coronavirus variant

Scientists at the Indian National Institute of Virology (NIV), Pune, have found that both Covaxin and Covishield produce half as many antibodies against the B.1.617 variant of the novel coronavirus as against the ‘original’ B.1 variant.  More...

UK: 487 reinfections for UK coronavirus variant B.1.1.7 and 13 reinfections already for B.1.617.2

The latest UK PHE technical report shows that there have been 487 cases of reinfection recorded for the UK variant B.1.1.7.  More...

UK: Chris Whitty – B.1.617.2 is more transmissible than B.1.1.7 coronavirus variant

Chris Whitty: at 11.15 minutes, “..there is now confidence, and SAGE has looked at this data, as have various modelling groups, that this variant (B.1.617.2) is more transmissible than B.1.1.7.”  More...

Cameroon: travel-driven emergence and spread of SARS-CoV-2 lineage B.1.620 with multiple VOC-like mutations and deletions in Europe

“In this study we have presented evidence that a SARS-CoV-2 lineage designated B.1.620, first detected in Europe in late February, is associated with Central Africa, where it appears to circulate at very high prevalence, and has been introduced into Europe and the US on multiple occasions.  More...

WHO: Newly designated VOC within lineage B.1.617 – update on Delta coronavirus variant

In consultation with the WHO SARS-CoV-2 Virus Evolution Working Group, WHO has determined that viruses within the lineage B.1.617 have been characterized as a VOC.  More...